Join to View Full Profile
1221 Madison St FL 2Seattle, WA 98104
Phone+1 206-386-2323
Dr. Devarakonda is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Siddhartha Devarakonda, MD is an oncologist based in Saint Louis, MO, specializing in genomics and thoracic oncology. He completed his internal medicine residency at St Luke's Hospital from 2011 - 2014 and furthered his specialization with a fellowship in Hematology and Medical Oncology at the Washington University/B-JH/SLCH Consortium from 2014 - 2017. Dr. Devarakonda has contributed to the medical community through publications in multiple medical journals on the topics of never-smoker lung cancer, treatment resistance in small cell lung cancer and molecular profiling of lung cancers.
Clinical Expertise
- Mesothelioma, Immunotherapy, Thymic tumors, Genomics, Thoracic oncology
Education & Training
Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 2014 - 2017
St Luke's HospitalResidency, Internal Medicine, 2011 - 2014
Gandhi Medical CollegeClass of 2009
Certifications & Licensure
IL State Medical License 2020 - 2026
WA State Medical License 2022 - 2025
MO State Medical License 2014 - 2024
Publications & Presentations
PubMed
- 2 citationsA pilot study of nintedanib in molecularly selected patients with advanced non-small cell lung cancer.Christine Auberle, Feng Gao, Mark Sloan, Daniel Morgensztern, Linda Winkler
Journal of Thoracic Disease. 2024-06-30 - 4 citationsOutcomes in Patients with Spinal Metastases Managed with Surgical Intervention.Brendan Knapp, Ashwin Govindan, Shalin S Patel, Kymberlie Pepin, Ningying Wu
Cancers. 2024-01-19 - 8 citationsPre-radiotherapy ctDNA liquid biopsy for risk stratification of oligometastatic non-small cell lung cancer.Nicholas P Semenkovich, Shahed N Badiyan, Pamela P Samson, Hayley B Stowe, Yun E Wang
NPJ Precision Oncology. 2023-10-02
Journal Articles
- Targeting Resistance to Targeted Therapies: Combating a Resilient FoeSiddhartha Devarakonda, Ramaswamy Govindan, Clinical Cancer Research
Authored Content
- Early Mortality in Patients Undergoing Adjuvant Chemotherapy for Non-Small-Cell Lung CancerFebruary 2018
Press Mentions
Some Lung Cancer Patients See Big Breakthrough with New DrugJune 11th, 2021- Friday: New Drug Provides Breakthrough for Some Lung Cancer PatientsJune 10th, 2021
Biomarkers Advances Continue to Drive Progress in NSCLCMay 3rd, 2017- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
